SK120498A3 - Pyrimido[5,4-d]pyrimidines, medicaments containing these compounds, their use and process for their production - Google Patents

Pyrimido[5,4-d]pyrimidines, medicaments containing these compounds, their use and process for their production Download PDF

Info

Publication number
SK120498A3
SK120498A3 SK1204-98A SK120498A SK120498A3 SK 120498 A3 SK120498 A3 SK 120498A3 SK 120498 A SK120498 A SK 120498A SK 120498 A3 SK120498 A3 SK 120498A3
Authority
SK
Slovakia
Prior art keywords
alkyl
substituted
group
imino
piperidinyl
Prior art date
Application number
SK1204-98A
Other languages
English (en)
Slovak (sk)
Inventor
Frank Himmelsbach
Georg Dahmann
Ruden Thomas Von
Thomas Metz
Original Assignee
Thomae Gmbh Dr K
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Thomae Gmbh Dr K filed Critical Thomae Gmbh Dr K
Publication of SK120498A3 publication Critical patent/SK120498A3/sk

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D487/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04Ortho-condensed systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/519Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/06Antipsoriatics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00Antineoplastic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Dermatology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
SK1204-98A 1996-03-06 1997-03-03 Pyrimido[5,4-d]pyrimidines, medicaments containing these compounds, their use and process for their production SK120498A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE19608653A DE19608653A1 (de) 1996-03-06 1996-03-06 Pyrimido[5,4-d]pyrimidine, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung
PCT/EP1997/001058 WO1997032882A1 (de) 1996-03-06 1997-03-03 PYRIMIDO[5,4-d]PYRIMIDINE, DIESE VERBINDUNGEN ENTHALTENDE ARZNEIMITTEL, DEREN VERWENDUNG UND VERFAHREN ZU IHRER HERSTELLUNG

Publications (1)

Publication Number Publication Date
SK120498A3 true SK120498A3 (en) 1999-04-13

Family

ID=7787391

Family Applications (1)

Application Number Title Priority Date Filing Date
SK1204-98A SK120498A3 (en) 1996-03-06 1997-03-03 Pyrimido[5,4-d]pyrimidines, medicaments containing these compounds, their use and process for their production

Country Status (23)

Country Link
US (1) US5977102A (xx)
EP (1) EP0885227A1 (xx)
JP (1) JP2000506153A (xx)
KR (1) KR19990087551A (xx)
CN (1) CN1212696A (xx)
AR (1) AR009937A1 (xx)
AU (1) AU712072B2 (xx)
BG (1) BG102790A (xx)
BR (1) BR9708004A (xx)
CA (1) CA2248316A1 (xx)
CO (1) CO4650044A1 (xx)
CZ (1) CZ281698A3 (xx)
DE (1) DE19608653A1 (xx)
EE (1) EE9800289A (xx)
HU (1) HUP9901750A2 (xx)
IL (1) IL125341A0 (xx)
NO (1) NO984081D0 (xx)
NZ (1) NZ331382A (xx)
PL (1) PL328776A1 (xx)
SK (1) SK120498A3 (xx)
TR (1) TR199801753T2 (xx)
WO (1) WO1997032882A1 (xx)
ZA (1) ZA971886B (xx)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR19990082463A (ko) 1996-02-13 1999-11-25 돈 리사 로얄 혈관 내피 성장 인자 억제제로서의 퀴나졸린유도체
CN1116286C (zh) 1996-03-05 2003-07-30 曾尼卡有限公司 4-苯胺基喹唑啉衍生物
UA71945C2 (en) * 1999-01-27 2005-01-17 Pfizer Prod Inc Substituted bicyclic derivatives being used as anticancer agents
JP3270834B2 (ja) * 1999-01-27 2002-04-02 ファイザー・プロダクツ・インク 抗がん剤として有用なヘテロ芳香族二環式誘導体
DE19911510A1 (de) * 1999-03-15 2000-09-21 Boehringer Ingelheim Pharma Bicyclische Heterocyclen, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung
NZ514477A (en) 1999-04-09 2003-04-29 Astrazeneca Ab Adamantane derivatives
US7049410B2 (en) * 1999-05-14 2006-05-23 Majumdar Adhip P N Antibodies to a novel EGF-receptor related protein (ERRP)
US6399743B1 (en) 1999-05-14 2002-06-04 Dept. Of Veterans Affairs Isolation and characterization of a rat epidermal growth factor related protein
PT1244647E (pt) 1999-11-05 2006-10-31 Astrazeneca Ab Derivados de quinazolina como inibidores de vegf
SE9904505D0 (sv) 1999-12-09 1999-12-09 Astra Pharma Prod Novel compounds
TWI258462B (en) 1999-12-17 2006-07-21 Astrazeneca Ab Adamantane derivative compounds, process for preparing the same and pharmaceutical composition comprising the same
CN1474815A (zh) * 2000-09-20 2004-02-11 Ĭ��ר���ɷ����޹�˾ 4-氨基-喹唑啉
BR0114021A (pt) * 2000-09-20 2003-08-19 Merck Patent Gmbh 4-amino-quinazolinas
US20030087919A1 (en) * 2001-03-23 2003-05-08 Bayer Corporation Rho-kinase inhibitors
US20030125344A1 (en) * 2001-03-23 2003-07-03 Bayer Corporation Rho-kinase inhibitors
US7829566B2 (en) * 2001-09-17 2010-11-09 Werner Mederski 4-amino-quinazolines
AU2003202263A1 (en) * 2002-01-10 2003-07-30 Bayer Healthcare Ag Roh-kinase inhibitors
CA2473910C (en) * 2002-01-23 2011-03-15 Bayer Pharmaceuticals Corporation Pyrimidine derivatives as rho-kinase inhibitors
JP4469179B2 (ja) * 2002-01-23 2010-05-26 バイエル ファーマセチカル コーポレーション Rhoキナーゼ阻害剤としてのピリミジン誘導体
KR101139038B1 (ko) * 2005-06-28 2012-05-02 삼성전자주식회사 피리미도피리미딘 유도체 및 이를 이용한 유기 박막 트랜지스터
AR073501A1 (es) 2008-09-08 2010-11-10 Boehringer Ingelheim Int Derivados de pirimido[5,4-d]pirimidina inhibidores de la tirosinoquinasa
US8569316B2 (en) 2009-02-17 2013-10-29 Boehringer Ingelheim International Gmbh Pyrimido [5,4-D] pyrimidine derivatives for the inhibition of tyrosine kinases
KR20120027177A (ko) * 2009-04-02 2012-03-21 메르크 파텐트 게엠베하 오토탁신 저해제로서의 피페리딘 및 피라진 유도체
US20130023531A1 (en) 2011-01-27 2013-01-24 Boehringer Ingelheim International Gmbh Pyrimido[5,4-d]pyrimidylamino phenyl sulfonamides as serine/threonine kinase inhibitors
WO2014175370A1 (ja) * 2013-04-25 2014-10-30 塩野義製薬株式会社 ピロリジン誘導体およびそれらを含有する医薬組成物
TW201607923A (zh) 2014-07-15 2016-03-01 歌林達有限公司 被取代之氮螺環(4.5)癸烷衍生物
CA2955071A1 (en) 2014-07-15 2016-01-21 Grunenthal Gmbh Substituted azaspiro(4.5)decane derivatives
PE20240327A1 (es) 2021-04-13 2024-02-22 Nuvalent Inc Heterociclos con sustitucion amino para tratar canceres con mutaciones de egfr

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3031450A (en) * 1959-04-30 1962-04-24 Thomae Gmbh Dr K Substituted pyrimido-[5, 4-d]-pyrimidines
EP0023559B1 (de) * 1979-07-03 1984-09-19 Dr. Karl Thomae GmbH 2-(Perhydro-1,4-diazino)-pyrimido(5,4-d)pyrimidine, ihre Herstellung und diese Verbindungen enthaltenden Arzneimittel
DE3049207A1 (de) * 1980-12-27 1982-07-29 Dr. Karl Thomae Gmbh, 7950 Biberach Neue trisubstituierte pyrimido (5,4-d) pyrimidine, ihre herstellung und ihre verwendung als arzneimittel
DE3423092A1 (de) * 1984-06-22 1986-01-02 Dr. Karl Thomae Gmbh, 7950 Biberach Neue 8-alkylthio-2-piperazino-pyrimido(5,4-d) pyrimidine, ihre herstellung und diese verbindungen enthaltende arzneimittel
US5034393A (en) * 1989-07-27 1991-07-23 Dowelanco Fungicidal use of pyridopyrimidine, pteridine, pyrimidopyrimidine, pyrimidopyridazine, and pyrimido-1,2,4-triazine derivatives
DE4325900A1 (de) * 1993-08-02 1995-02-09 Thomae Gmbh Dr K Trisubstituierte Pyrimido [5,4-d] pyrimidine zur Modulation der Multidrugresistenz, diese Verbindungen enthaltende Arzneimittel und Verfahren zu ihrer Herstellung
IL112249A (en) * 1994-01-25 2001-11-25 Warner Lambert Co Pharmaceutical compositions containing di and tricyclic pyrimidine derivatives for inhibiting tyrosine kinases of the epidermal growth factor receptor family and some new such compounds
TW414798B (en) * 1994-09-07 2000-12-11 Thomae Gmbh Dr K Pyrimido (5,4-d) pyrimidines, medicaments comprising these compounds, their use and processes for their preparation
DE4431867A1 (de) * 1994-09-07 1996-03-14 Thomae Gmbh Dr K Pyrimido[5,4-d]pyrimidine, diese Verbindungen enthaltende Arzneimittel, deren Verwendung und Verfahren zu ihrer Herstellung

Also Published As

Publication number Publication date
WO1997032882A1 (de) 1997-09-12
JP2000506153A (ja) 2000-05-23
EE9800289A (et) 1999-02-15
DE19608653A1 (de) 1997-09-11
CN1212696A (zh) 1999-03-31
NZ331382A (en) 1999-08-30
NO984081L (no) 1998-09-04
EP0885227A1 (de) 1998-12-23
CZ281698A3 (cs) 1999-02-17
CO4650044A1 (es) 1998-09-03
BG102790A (bg) 1999-09-30
AU712072B2 (en) 1999-10-28
HUP9901750A2 (hu) 1999-09-28
NO984081D0 (no) 1998-09-04
PL328776A1 (en) 1999-02-15
AR009937A1 (es) 2000-05-17
KR19990087551A (ko) 1999-12-27
AU1925297A (en) 1997-09-22
TR199801753T2 (xx) 1998-12-21
US5977102A (en) 1999-11-02
BR9708004A (pt) 1999-07-27
CA2248316A1 (en) 1997-09-12
IL125341A0 (en) 1999-03-12
ZA971886B (en) 1998-09-07

Similar Documents

Publication Publication Date Title
SK120498A3 (en) Pyrimido[5,4-d]pyrimidines, medicaments containing these compounds, their use and process for their production
AU710274B2 (en) 4-amino-pyrimidine derivates, medicaments containing these compounds, their use and process for their production
KR100597505B1 (ko) 4-아미노-6-페닐-피롤로[2,3-d]피리미딘 유도체
JP5941513B2 (ja) Bcr−ablの低分子のミリスチン酸エステル阻害剤及びその使用方法
SK120898A3 (en) Pyrimido[5,4-d]pyrimidines, medicaments containing these compounds, their use and process for their production
JP4970689B2 (ja) キナゾリン化合物
CN103958512B (zh) 3,5-双取代炔基苯化合物及其盐
EP2167492B1 (en) Novel amide derivative for inhibiting the growth of cancer cells
SK284277B6 (sk) Pyrimido[5,4-d]pyrimidíny, spôsob ich výroby, liečivo s ich obsahom a ich použitie
CN104066723B (zh) 1-(芳基甲基)-5,6,7,8-四氢喹唑啉-2,4-二酮和相关化合物及其应用
JP2020502065A (ja) 8,9−ジヒドロイミダゾール[1,2−a]ピリミド[5,4−e]ピリミジン−5(6H)−ケトン類化合物
SK13032001A3 (sk) Bicyklické heterocyklické zlúčeniny, spôsob ich prípravy, farmaceutický prostriedok s ich obsahom a ich použitie
JP2010505859A (ja) タンパク質キナーゼ阻害剤およびそれを使用するための方法
AU2011296024A1 (en) Quinazoline compounds and methods of use thereof
CA2378291A1 (en) Quinazoline derivatives
JP2010525047A (ja) 増殖状態の処置のためのEphB4キナーゼ阻害剤としてのN’−(フェニル)−N−(モルホリン−4−イル−ピリジン−2−イル)−ピリミジン−2,4−ジアミン誘導体
WO2000055162A2 (en) Bicyclic heterocycles, pharmaceutical compositions containing these compounds, their use and processes for preparing them
EP1742937B1 (en) Pyrrolopyrimidine derivatives for treating proliferative diseases
WO2016115869A1 (zh) Flt3激酶的新型抑制剂及其用途
EP3896059B1 (en) Pan-kit kinase inhibitor having quinoline structure and application thereof
KR100395271B1 (ko) 피리미도[5,4-d]피리미딘및이를포함하는약제
MXPA98007154A (en) Pirimido [5,4-d] pyrimidinas, medicines containing these compounds, its employment and procedures for its preparation